|
SPATA5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.12489999537502E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.48590000029303E-07 |
| Normal-vs-Stage2 |
2.56350000005234E-06 |
| Normal-vs-Stage3 |
4.93229999998235E-06 |
| Normal-vs-Stage4 |
1.19220000005527E-06 |
| Stage1-vs-Stage2 |
2.196200E-01 |
| Stage1-vs-Stage3 |
9.264200E-01 |
| Stage1-vs-Stage4 |
3.227800E-01 |
| Stage2-vs-Stage3 |
2.979000E-01 |
| Stage2-vs-Stage4 |
8.047400E-01 |
| Stage3-vs-Stage4 |
4.008200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.54220000395611E-08 |
| Normal-vs-AfricanAmerican |
4.998300E-02 |
| Normal-vs-Asian |
9.76520000000036E-05 |
| Caucasian-vs-AfricanAmerican |
1.717780E-01 |
| Caucasian-vs-Asian |
9.229200E-01 |
| AfricanAmerican-vs-Asian |
2.211400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.7685999999002E-07 |
| Normal-vs-Female |
1.26989999960081E-07 |
| Male-vs-Female |
5.164000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.5896999999997E-06 |
| Normal-vs-Age(41-60Yrs) |
4.70320005163671E-09 |
| Normal-vs-Age(61-80Yrs) |
1.69938999999841E-05 |
| Normal-vs-Age(81-100Yrs) |
4.152000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.808580E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.575200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.209200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.102200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.380800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.453400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.596400E-01 |
| Classical-VS-Follicular |
3.75550000000224E-05 |
| Classical-VS-Other |
1.001440E-01 |
| Classical-VS-Normal |
4.88480000004898E-06 |
| Tall-VS-Follicular |
1.089020E-01 |
| Tall-VS-Other |
2.380400E-01 |
| Tall-VS-Normal |
5.579700E-04 |
| Follicular-VS-Other |
8.169000E-01 |
| Follicular-VS-Normal |
1.00880004350046E-09 |
| Other-VS-Normal |
3.401700E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.44189995896238E-09 |
| Normal-vs-N1 |
4.37819999999922E-05 |
| N0-vs-N1 |
5.724000E-01 |
|
|
